HR 9127
117th Congress
House
Health
Medical research
Medicare
Prescription drugs
Mandating Exclusive Review of Individual Treatments (MERIT) Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 5, 2022
Referred to the Subcommittee on Health.
Oct 4, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 4, 2022
Introduced in House
Plain-English summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3